IL2 and neoplasm: However, IL-2 concomitantly acts on Tregs that suppress anti-tumor responses, and systemic IL-2 injections had severe adverse effects including vascular leak syndrome and pulmonary edema due to IL-2Rα expression on endothelial cells [109].